Today: 12 May 2026
Arm Stock Surges Before Earnings as AI Server CPU Bet Faces Wall Street Test

Arm Stock Surges Before Earnings as AI Server CPU Bet Faces Wall Street Test

LONDON, May 6, 2026, 15:00 (BST)

Arm Holdings plc’s U.S. shares jumped $22.58 to hit $231.42 in New York morning trading Wednesday, up roughly 11%, ahead of the British chip designer’s fiscal fourth-quarter report due after the bell. The rally pushed Arm squarely into focus again for the AI-chip trade, which has shifted recently from graphics chips over to server CPUs.

Arm plans to release its earnings following the U.S. market close, with a management webcast set for 22:00 British Summer Time. Investors are zeroed in on the timing, eager for any sign that AI infrastructure demand is boosting more than just Nvidia-like graphics chips—especially clues that Arm’s designs are grabbing ground in data centers.

Advanced Micro Devices’ upbeat outlook late Tuesday kicked off a wave of buying, driving up semiconductor stocks and putting CPUs back in the spotlight. While GPUs still dominate for training massive AI models, CPUs are starting to matter more as businesses deploy those models in real-world products and agent-based systems. Arm shares climbed as well, moving in step with AMD, Intel, and other chipmakers, according to Reuters. Matt Britzman at Hargreaves Lansdown called AMD’s narrative “a broader compute opportunity.” Reuters

Analysts surveyed by Visible Alpha are predicting Arm will post revenue of $1.47 billion for the fiscal fourth quarter, with adjusted earnings coming in at 59 cents per share. Options markets are flashing the potential for a 10% swing in the stock by week’s end. That kind of move suggests that, even with a strong quarter, the debate over Arm’s valuation is unlikely to be put to rest.

UBS boosted its price target for Arm, lifting it to $245 from $175 this week and sticking with its buy call. The bank cited swelling demand for server CPUs as AI use cases take off. UBS now sees the server CPU market swelling from around $30 billion in 2025 to as much as $170 billion by 2030, a surge expected to lift Arm, Intel, and AMD alike.

Arm’s main business remains licensing chip designs and earning royalties whenever its architecture shows up in partners’ chips. According to the company, over 350 billion Arm-based chips have shipped so far—a scale that started with mobile phones and has since expanded into cloud servers, automotive, and embedded devices.

Now the next big question: just how much further can Arm push past its standard licensing playbook? In March, Arm rolled out the Arm AGI CPU, its debut foray into making silicon products for AI data centers—Meta signed on as both lead partner and co-developer. Arm CEO Rene Haas called AI a force that’s “fundamentally redefined” computing. For Meta, infrastructure chief Santosh Janardhan claims the new chip should ramp up data-center performance density. Arm Newsroom

In Arm’s launch materials, OpenAI’s industrial compute chief Sachin Katti said the new AGI CPU “will play an important role” as OpenAI’s infrastructure grows. Partner comments like these give investors more to work with than just a product roadmap, but the real test—big revenue from fresh silicon—remains to be seen. Arm Newsroom

Arm has taken to the Open Compute Project forum to advocate for AI infrastructure standards, rolling out reference server designs and system-readiness programs linked to the AGI CPU. According to Arm, European cloud player Verda is putting the chip to work next to Nvidia GB300-based machines, and plans to use it with upcoming Vera Rubin systems.

There’s a real chance that sentiment has outpaced what Arm can actually deliver right now. The stock had climbed nearly 90% for the year heading into Wednesday’s report. Even so, Visible Alpha’s consensus target sat comfortably under the share price quoted ahead of earnings. Any sign of just average guidance, rising costs, or lagging data-center momentum—those could all put pressure on the stock.

This earnings report isn’t just another quarterly checkpoint. It’s more of a litmus test for a broader market narrative. Investors are trying to figure out if Arm remains largely a royalty engine anchored in phones and consumer tech, or if it’s shifting toward a more active role in the AI-server push that’s been moving chip stocks lately.

Stock Market Today

  • QuantumScape Shares Rise 9.35% After Q1 Earnings Beat Expectations
    May 12, 2026, 5:51 PM EDT. QuantumScape Corporation (NASDAQ: QS) shares jumped 9.35% following its Q1 2026 earnings report, which showed a smaller-than-expected loss of $0.16 per share versus Wall Street's forecast of $0.18. Despite continuing losses of $100.8 million driven by heavy R&D spending, QS's strong cash position of $904.7 million and a working capital cushion of $872.1 million reassure investors. The stock's advance from mid-$6s in late April to around $8.26 on May 11 reflects growing optimism about the firm's solid-state lithium-metal battery technology. Market participants remain focused on progress toward commercialization, with robust trading momentum indicating confidence in QS's potential for electric vehicle applications.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
IonQ Earnings Today: $500 Stock Talk Meets a Quantum Reality Check
Previous Story

IonQ Earnings Today: $500 Stock Talk Meets a Quantum Reality Check

Palantir Stock Just Sank After a Blowout Quarter. Wall Street Is Finding the One Thing It Didn’t Like
Next Story

Palantir Stock Just Sank After a Blowout Quarter. Wall Street Is Finding the One Thing It Didn’t Like

Go toTop